We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Epigenomics Receives FDA Approval for Epi proColon®

News   Apr 16, 2016

 
Epigenomics Receives FDA Approval for Epi proColon®
 
 
 

RELATED ARTICLES

New Prostate Cancer Blood Test Detects Early Treatment Failure

News

This new liquid biopsy helps to track and respond to prostate cancer evolution, and identify emerging drug resistance.

READ MORE

Overhaul of Colorectal Cancer Screening System Saves Lives

News

Members of Kaiser Permanente are 52% less likely to die from colorectal cancer thanks to an organized screening program.

READ MORE

Artificial Intelligence Model “Learns” from Patient Data to Make Cancer Treatment Less Toxic

News

Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE